Clinical Trial Update: Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development [Phase 3]

View source ↗

Summary

Phase 3 trial of Biostate for treatment of children with Hemophilia A and antibody development was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Biostate (plasma-derived von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia A | Phase 3 | Status: TERMINATED